Back
Anavex Life Sciences Corp. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
26
AVXL
Anavex Life Sciences Corp.
Last Price:
$4.45
Seasonality Move:
3.46%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAnavex Life Sciences Corp. Stock Forecast
-
Is Anavex Life Sciences Corp. Stock Undervalued?The current Anavex Life Sciences Corp. [AVXL] share price is $4.45. The Score for AVXL is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
AVXL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Anavex Life Sciences Corp. Stock Go Up Next Year?
Data Unavailable
Anavex Life Sciences Corp. Stock Rating
Data Unavailable
Anavex Life Sciences Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
anavex.com
52-Week Data
52-Week High:
14.44
52-Week Low:
2.86
Prediction Charts
Market Cap:
397.6M
Price in USD:
4.45
Volume:
1.9M
Beta:
-0.42
Technical Analysis
SMA50:
7.12
SMA100:
8.64
SMA200:
8.74
52-Wk Change:
-50.88%
Stock Predictions
-
Is Anavex Life Sciences Corp. stock public?Yes, Anavex Life Sciences Corp. is a publicly traded company.
-
What is the Anavex Life Sciences Corp. stock quote today?The Anavex Life Sciences Corp. stock price is 4.45 USD today.
-
How to buy Anavex Life Sciences Corp. stock online?You can buy Anavex Life Sciences Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 2.96 | 3.65 | 4.14 | 2.86 |
| Nov-17 | 3.50 | 3.58 | 4.04 | 3.28 |
| Nov-18 | 3.54 | 3.50 | 3.64 | 3.44 |
| Nov-19 | 3.47 | 3.60 | 3.74 | 3.40 |
| Nov-20 | 3.58 | 3.17 | 3.65 | 3.05 |
| Nov-21 | 3.17 | 3.26 | 3.37 | 3.13 |
| Nov-24 | 3.23 | 3.08 | 3.29 | 3.00 |
| Nov-25 | 3.29 | 3.46 | 3.69 | 3.18 |
| Nov-26 | 3.55 | 3.86 | 3.92 | 3.46 |
| Nov-28 | 3.93 | 3.83 | 3.96 | 3.73 |
| Dec-1 | 3.84 | 3.82 | 4.05 | 3.68 |
| Dec-2 | 3.80 | 3.67 | 3.94 | 3.62 |
| Dec-3 | 3.80 | 4.57 | 4.84 | 3.80 |
| Dec-4 | 4.49 | 4.45 | 4.58 | 4.29 |
Anavex Life Sciences Corp. Earnings
Data Unavailable
Anavex Life Sciences Corp. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.10 per share.
* Anavex Life Sciences Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.